23 May 2013
Keywords: lilly, repligen, expand, biotech, deal, eli, agreed
Article | 12 June 1995
Repligen and Eli Lilly have agreed to renew their biotechnology and genetic engineering licensing agreement and extend it through 1996. The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.